Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study - Abraham, E; Reinhart, K; Svoboda, P (Crit Care Med, 2001)
, et al.